Combination therapy targeting the elevated interleukin‐6 level reduces invasive migration of BRAF inhibitor‐resistant melanoma cells-Reference-Cited by-同舟云学术

Combination therapy targeting the elevated interleukin‐6 level reduces invasive migration of BRAF inhibitor‐resistant melanoma cells

Published:2019-01-10 Issue:2 Volume:13 Page:480-494
ISSN:1574-7891
Container-title:Molecular Oncology
language:en
Short-container-title:Mol Oncol

Author:

Mohapatra Purusottam¹,Prasad Chandra Prakash¹,Andersson Tommy¹

Affiliation:

1. Cell and Experimental Pathology Department of Translational Medicine Clinical Research Centre Skåne University Hospital Lund University Malmö Sweden

Funder

Swedish Cancer Foundation

Gunnar Nilssons Cancerstiftelse

Skånes universitetssjukhus

Kungliga Fysiografiska Sällskapet i Lund

Vetenskapsrådet

Publisher

Wiley

Subject

Cancer Research,Genetics,Molecular Medicine,General Medicine,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/1878-0261.12433

Reference28 articles.

1. WNT5A enhances resistance of melanoma cells to targeted BRAF inhibitors

2. Development, Characterization, and Reversal of Acquired Resistance to the MEK1 Inhibitor Selumetinib (AZD6244) in an In Vivo Model of Childhood Astrocytoma

3. eIF4F is a nexus of resistance to anti-BRAF and anti-MEK cancer therapies

4. Loss of Klotho during melanoma progression leads to increased filamin cleavage, increased Wnt5A expression, and enhanced melanoma cell motility

5. WNT5A Expression Increases during Melanoma Progression and Correlates with Outcome

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 7‐amino carboxycoumarin 2 inhibits lactate induced epithelial‐to‐mesenchymal transition via MPC1 in oral and breast cancer cells;Cell Biology International;2024-05-21

2. Upregulated expression of miR-4443 and miR-4488 in drug resistant melanomas promotes migratory and invasive phenotypes through downregulation of intermediate filament nestin;Journal of Experimental & Clinical Cancer Research;2023-11-27

3. Obstetric Results after Fertility-Sparing Management of Non-Epithelial Ovarian Cancer;Cancers;2023-08-18

4. BRAF Mutations in Melanoma: Biological Aspects, Therapeutic Implications, and Circulating Biomarkers;Cancers;2023-08-08

5. Helper Innate Lymphoid Cells—Unappreciated Players in Melanoma Therapy;Cancers;2023-02-01